Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium

Vaccine

Volumn 26, Issue 29-30, 2008, Pages 3680-3689

  Toriniwa, Hiroko ^a   Komiya, Tomoyoshi ^a  

^a KITASATO INSTITUTE   (Japan)

Author keywords

Japanese encephalitis virus; Serum free medium; Stability

Indexed keywords

ALCOHOL; ENCEPHALITIS VACCINE; FORMALDEHYDE; GLUTAMINE; GLYCINE; INACTIVATED VACCINE; LACTOSE; SORBITOL;

ANIMAL CELL; ARTICLE; BIOSAFETY; BRAIN; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; EPIDEMIC ENCEPHALITIS; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE TEMPERATURE; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VERO CELL; VIRUS INACTIVATION; VIRUS PURIFICATION;

ANIMALS; ANTIBODIES, VIRAL; CELL CULTURE TECHNIQUES; CENTRIFUGATION, DENSITY GRADIENT; CERCOPITHECUS AETHIOPS; CHEMICAL FRACTIONATION; CULTURE MEDIA, SERUM-FREE; DRUG STABILITY; ENCEPHALITIS VIRUS, JAPANESE; FEMALE; GLYCINE; JAPANESE ENCEPHALITIS VACCINES; MICE; NEUTRALIZATION TESTS; SORBITOL; TEMPERATURE; VERO CELLS; VIRUS INACTIVATION;

EID: 45049087609     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.076     Document Type: Article

References (27)

1. Burke D.S., and Monath T.P. Fields virology. 4th ed. (2001), Lippincott, Philadelphia p. 991-1055
2. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting. Bangkok, Thailand, 13-15 October 1998. Vaccine 18 (2000) 1-25
3. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44 (1990) 649-688
4. Srivastava A.K., Aira Y., Mori C., Kobayashi Y., and Igarashi A. Antigenicity of Japanese encephalitis virus envelope glycoprotein V3 (E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blotting. Arch Virol 96 (1987) 97-107
5. Konishi E., Yamaoka M., Khin-Sane-Win, Kurane I., Takada K., and Mason P.W. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 73 (1999) 5527-5534
6. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine 19 (2001) 4557-4565
7. Sugawara K., Nishiyama K., Ishikawa Y., Abe M., Sonoda K., Komatsu K., et al. Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals 30 (2002) 303-314
8. World Health Organization. Requirements for continuous cell lines used for biological substances. WHO Tech Rep Ser 1987;745:99-115.
9. World Health Organization. Acceptability of cell substrates for production of biologicals. WHO Tech Rep Ser 1987;747:5-24.
10. Toriniwa H., and Komiya T. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Biologicals 35 (2007) 221-226
11. Froud S.J. The development, benefits and disadvantages of serum-free media. Dev Biol Stand 99 (1999) 157-166
12. Butler M., Burgener A., Patrick M., Berry M., Moffatt D., Huzel N., et al. Application of a serum-free medium for the growth of Vero cells and the production of reovirus. Biotechnol Prog 16 (2000) 854-858
13. Frazatti-Gallina N.M., Mourao-Fuches R.M., Paoli R.L., Silva M.L.N., Miyaki C., Valentini E.J.G., et al. Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23 (2004) 511-517
14. Wu S.C., and Huang G.Y. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Biotechnol Prog 18 (2002) 124-128
15. Miyaki C., Pral M.M., Gallina N.M.F., and Rizzo E. Mycoplasma as a contaminant of cell cultures maintained in laboratories of private and official institutions. Rev Saude Publ 23 (1989) 39-44
16. Assaf S.L.M.R., Yokomizo A.Y., Serapicos E.O., Frazatti-Gallina N.M., and Machado L.D. Tumorigenicity testing of VERO cells. Arq Biol Technol 40 (1997) 593-600
17. Minimum requirements for biological products. Japan: National Institute of Infectious Diseases; 2006.
18. Guidance for Industry. Characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases. Draft guidance. Food and Drug Administration Center for Biologics Evaluation and Research; 2006.
19. Toriniwa H., and Komiya T. Rapid detection and quantification of Japanese encephalitis virus by real-time reverse transcription loop-mediated isothermal amplification. Microbiol Immunol 50 (2006) 379-387
20. Kimura-Kuroda J., and Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J Gen Virol 67 (1986) 2663-2672
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 15 (1970) 680-685
22. Igarashi A. Isolation of a Singh's adedes albopictus cells clone sensitive to Dengue and Chikungunya viruses. J Gen Virol 40 (1978) 531-544
23. Ishikawa T., Yoshii H., Onishi T., Ishibashi M., and Imakawa T. Development of an inactivated Japanese encephalitis vaccine by utilizing a continuous cell line. Clin Virol 26 (1998) 340-350 [in Japanese]
24. Rourou S., van der Ark A., van der Velden T., and Kallel H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine 10 (2007) 3879-3889
25. Wolter T., and Richter A. Assays for controlling host-cell impurities in biopharmaceuticals. Bioprocess Tech Feb (2005) 40-46
26. Yoshida Y., Tabei Y., Hasegawa M., Nagashima M., and Morozumi S. Genotypic analysis of Japanese encephalitis virus strains isolated from swine in Tokyo, Japan. Jpn J Infect Dis 58 (2005) 259-261
27. Appaiahgari M.B., and Vrati S. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated India strain of Japanese encephalitis virus grown in Vero cells. Vaccine 22 (2004) 3669-3675